Macrogen, Inc. (KOSDAQ: 038290)

Market Cap	163.86B
Revenue (ttm)	131.73B
Net Income (ttm)	-21.73B
Shares Out	9.98M
EPS (ttm)	-2,175.92
PE Ratio	n/a
Forward PE	20.58
Dividend	300.00 (1.83%)
Ex-Dividend Date	Dec 27, 2024

Volume	31,293
Open	16,500
Previous Close	16,890
Day's Range	16,500 - 16,790
52-Week Range	14,700 - 26,700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S...

• Industry: Commercial Physical and Biological Research
• Founded: 1997
• Employees: 519
• Stock Exchange: KOSDAQ
• Ticker Symbol: 038290

Financial Performance

In 2023, Macrogen's revenue was 132.80 billion, a decrease of -4.19% compared to the previous year's 138.62 billion. Losses were -16.81 billion, -24.44% less than in 2022.